Salomon & Ludwin’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9K Hold
57
– – ﹤0.01% 1209
2026
Q2
$12K Hold
57
– – ﹤0.01% 1505
2026
Q1
$10.1K Hold
57
– – ﹤0.01% 1519
2025
Q4
$10K Hold
57
– – ﹤0.01% 1442
2025
Q3
$9.11K Buy
+57
New +$7.7K ﹤0.01% 1381

Other funds holding BIIB

Salomon & Ludwin's BIIB Position: Q3 2026 in Review

Salomon & Ludwin held its Biogen (BIIB) position steady in Q3 2026 at 57 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Salomon & Ludwin first reported a position in BIIB in Q3 2025 and has held it in 5 quarters since. 933 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Salomon & Ludwin held 57 shares of Biogen worth $12.9K as of Q3 2026.
  • Salomon & Ludwin left its Biogen share count unchanged in Q3 2026.
  • Biogen made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1209 holding.
  • Salomon & Ludwin first reported a position in Biogen in Q3 2025 and has held it in 5 quarters since.
  • 933 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.